Renaud Savary
Advertisement
Renaud Savary is Senior Investment Analyst, Pharmaceutical Sector, at Avem Capital.
Articles by Renaud Savary
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Releases Updated Safety Data for Foundayo Following FDA’s Request
2
FDA’s Shift Signals a New Era for Data-Driven Drug Development
3
How Are Regulatory Factors Impacting Biosimilars
4
Obsidian Therapeutics and Galera Therapeutics Enter $350 Million Merger Agreement
5